Neumora Therapeutics, Inc.

NMRA · Healthcare · Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, ne…

Neumora Therapeutics, Inc. (NMRA), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 2 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 20 and filed Aug 21. The most active filer was Daljit Singh Aurora with 2 filings. Data as of Nov 7 2026.

Add to watchlist

Filings, ttm

0 buys · 2 sells

Traders, ttm

1 insider

Volume, ttmiDollar value disclosed in the window

$204K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 20

Filed Aug 21

ADViAverage daily dollar volume

$3.2M

market data

Share price · 12M

$1.39 (-50.5%)

Adjusted for splits and dividends.

Volume by month

Buys $15.0M Sells $511K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

Daljit Singh Aurora See Remarks 2 filings · 0 buys, 2 sales AL ARCH Venture Partners X, LLC 10% owner 1 filing · 1 buy, 0 sales AL ARCH Venture Partners XII, LLC 10% owner 1 filing · 1 buy, 0 sales KB

Kristina Burow Director 1 filing · 1 buy, 0 sales

Recent filings

Daljit Singh AuroraSALE See Remarks $204K
134,452 sh across 2 lots
Exec Aug 20
Filed Aug 21 · 7:10 PM ET Daljit Singh AuroraSALE See Remarks $307K
114,703 sh × $2.68
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET Kristina BurowPURCHASE Director $5.0M
1,915,700 sh × $2.61
Exec Oct 27 2025
Filed Oct 29 2025 · 7:22 PM ET ARCH Venture Partners XII, LLCPURCHASE 10% owner $5.0M
1,915,700 sh × $2.61
Exec Oct 27 2025
Filed Oct 29 2025 · 7:21 PM ET ARCH Venture Partners X, LLCPURCHASE 10% owner $5.0M
1,915,700 sh × $2.61
Exec Oct 27 2025
Filed Oct 29 2025 · 7:19 PM ET